- Astrotech Corporation reported a **net loss of $(13.850) million**, or **$(8.32) per common share**, on **$1.0 million in revenue** for the fiscal year ended June 30, 2025, with revenue decreasing from the prior year.  **[1001907_0001437749-25-029876_ex_860711.htm:0]** **[1001907_0001437749-25-029876_ex_860711.htm:2]** 
- The company's gross margin **increased to 45.3%** for fiscal year 2025, up from 45.1% in the prior year, attributed to higher margin device sales.  **[1001907_0001437749-25-029876_ex_860711.htm:0]** 
- As of June 30, 2025, Astrotech held **$18.2 million in cash and cash equivalents and liquid investments**, a notable decrease from the prior fiscal year.  **[1001907_0001437749-25-029876_ex_860711.htm:0]** **[1001907_0001437749-25-029876_ex_860711.htm:2]** 
- Operationally, Astrotech formed **EN-SCAN, Inc.** for environmental testing and its 1st Detect subsidiary launched the enhanced **TRACER 1000 Narcotics Trace Detector**.  **[1001907_0001437749-25-029876_ex_860711.htm:0]** 
- 1st Detect also secured a research and development contract with the Department of Homeland Security on **January 14, 2025**, for next-generation explosives trace detection.  **[1001907_0001437749-25-029876_ex_860711.htm:0]**

ASTROTECH (ASTC)